Loading...
Loading...
AETHLON MEDICAL INC
AETHLON MEDICAL INC. Spoken Alpha tracks AEMD's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks AEMD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 4/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AEMD.
curl https://api.spokenalpha.com/v1/companies/AEMD| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.21 | $1.31 | -7.9% | +1.2% | -0.4% |
| Q4 FY2026 | $1.13 | $1.24 | -9.0% | +3.9% | +4.9% |
| Q3 FY2026 | $1.19 | $1.31 | -9.4% | +0.5% | -1.9% |
| Q2 FY2026 | $1.25 | $1.40 | -10.5% | -0.1% | -1.3% |
| Q1 FY2025 | $1.15 | $1.25 | -8.2% | -0.4% | -2.4% |
| Q4 FY2025 | $1.50 | $1.46 | +2.6% | -3.2% | -1.2% |
| Q3 FY2025 | $1.42 | $1.39 | +2.3% | +7.8% | +4.9% |
| Q2 FY2025 | $1.54 | $1.53 | +0.4% | +1.1% | +1.2% |
| Q1 FY2024 | $1.36 | $1.32 | +2.9% | +3.7% | +5.4% |
| Q4 FY2024 | $1.20 | $1.30 | -7.5% | +2.3% | +0.1% |